COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

<< Previous

Bullboard Posts

Next >>

Post by Hopeforthebeston Jul 10, 2024 7:21pm

135 Views

Post# 36127433

Re: NoShowRonnie

Proph, there is a saying in business and one that applies here, "What have you done for me lately" well Lately NoShowRonnie has done absolutely nothing except on a couple occasions he is a mouthpiece puppet for gagnon. His only accomplishment at Ceapro and now Aezs is to decrease Shareholder Value while delivering zero deliverables
Class A failure but still lines his pocket

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide